44 results
DEFM14A
TGAN
Transphorm Inc
4 Mar 24
Proxy related to merger
5:18pm
is terminated without “cause” and other than due to the participant’s death or “disability,” or the
participant resigns in a “good reason termination … their earlier death, resignation or removal. At the effective time of the merger, the officers of the surviving corporation will be the officers of Transphorm
PREM14A
TGAN
Transphorm Inc
23 Feb 24
Preliminary proxy related to merger
5:26pm
is terminated without “cause” and other than due to the participant’s death or “disability,” or the participant resigns in a “good reason termination … are duly elected or appointed and qualified, or until their earlier death, resignation or removal. At the effective time of the merger, the officers
DEFA14A
TGAN
Transphorm Inc
11 Jan 24
Additional proxy soliciting materials
9:09am
of incorporation and bylaws of the Surviving Corporation until their respective successors are duly elected and qualified, or until their earlier death … their respective successors are duly appointed, or until their earlier death, resignation or removal.
2.7 Effect on Capital Stock.
(a) Capital
8-K
EX-2.1
TGAN
Transphorm Inc
11 Jan 24
Renesas to Acquire Transphorm to Expand its Power Portfolio with GaN Technology
9:05am
of the Surviving Corporation until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal.
(b … successors are duly appointed, or until their earlier death, resignation or removal.
2.7 Effect on Capital Stock.
(a) Capital Stock. Upon the terms
8-K
EX-10.1
hx1g3a4d
8 Aug 23
Departure of Directors or Certain Officers
4:06pm
8-K
bzvs 95rt0iu
27 Jul 23
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.1
7j7 irjr6iht9nr
27 Jul 23
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.1
bjp16nn2ofj56xp5
23 May 23
Entry into a Material Definitive Agreement
8:50am
10-KT
EX-10.15.4
m7xrxczek0 j3m1svbwb
23 Jun 21
Annual report (with FYE transition)
9:55pm
424B3
n8f365p999ct61q3zhvi
27 Jan 21
Prospectus supplement
4:32pm
424B3
EX-10.1
nvn2t1i6fe37 iwtqru
30 Dec 20
Prospectus supplement
4:16pm
8-K
EX-10.1
usep9er danguydps2fx
30 Dec 20
Transphorm Announces Closing of $15 Million Private Placement of Common Stock
9:10am
424B3
EX-10.1
j2m8uw353lny tf
10 Nov 20
Prospectus supplement
9:30pm